GlassScriptPhysician profile
Matthew B Kaufman
NPI 1871600353
$13,661.87
in general payments reported to CMS, 2019-2025
32 companies · $5,613 in 2025
The $5,613 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $761 · 2021: $774 · 2022: $2,099 · 2023: $1,896 · 2024: $1,868 · 2025: $5,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,477 · Consulting Fee: $3,750 · Education: $123 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,476.50 |
| Consulting Fee | $3,750.00 |
| Education | $123.33 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $5,320.14 | 2023-2025 | Lensar Laser System |
| Alcon Vision LLC | $1,815.91 | 2019-2025 | Clareon, Unity, Luxor |
| Biotissue Holdings INC. | $1,797.66 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,427.63 | 2019-2025 | Cequa |
| Rxsight INC | $357.07 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $348.33 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $343.33 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $316.64 | 2022-2025 | Stellaris, Envista Envy Iol, Miebo |
| Glaukos Corporation | $296.15 | 2021-2023 | Istent Trabecular Micro-Bypass Stent System, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade |
| Oyster Point Pharma, INC. | $227.23 | 2022-2025 | Tyrvaya |
| Abbvie INC. | $145.40 | 2022-2025 | |
| Harrow Eye, LLC | $122.67 | 2025 | Vevye |
| Kala Pharmaceuticals, INC. | $119.59 | 2021-2022 | |
| Dompe US, INC. | $119.55 | 2019-2025 | Oxervate |
| Rayner Intraocular Lenses Limited | $118.31 | 2025 | Rayner Cataract Set 1, Rayone Aspheric, Rayone Emv |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $114.07 | 2019-2021 | |
| Axonics, INC. | $110.38 | 2020 | |
| Novartis Pharmaceuticals Corporation | $92.56 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $86.84 | 2021-2024 | Acthar |
| Amgen INC. | $72.10 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $66.85 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $45.00 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $33.63 | 2025 | Xdemvy |
| Sight Sciences, INC. | $24.15 | 2023 | Omni Surgical System |
| Omeros Corporation | $22.03 | 2019 | |
| Dornier Medtech America, INC | $19.53 | 2020 | |
| Ivantis, INC | $18.83 | 2019 | |
| Eyevance Pharmaceuticals LLC | $16.94 | 2020 | |
| Tearlab Corp | $16.62 | 2024 | Scoutpro Osmolarity System |
| Shire North American Group INC | $16.44 | 2019 | |
| Aerie Pharmaceuticals, INC. | $16.44 | 2019 | |
| Iridex Corporation | $13.85 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.